STEAP2
Basic information
Region (hg38): 7:90167590-90238137
Previous symbols: [ "PCANAP1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STEAP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 29 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 29 | 3 | 1 |
Variants in STEAP2
This is a list of pathogenic ClinVar variants found in the STEAP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-90225078-G-A | STEAP2-related disorder | Likely benign (Sep 13, 2019) | ||
7-90225089-T-C | not specified | Uncertain significance (Oct 17, 2024) | ||
7-90225092-A-G | not specified | Uncertain significance (Jan 02, 2024) | ||
7-90225098-A-G | not specified | Uncertain significance (Oct 02, 2023) | ||
7-90225108-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
7-90225138-C-T | not specified | Uncertain significance (Oct 09, 2024) | ||
7-90225155-A-G | not specified | Uncertain significance (Sep 10, 2024) | ||
7-90225195-G-A | not specified | Uncertain significance (Nov 14, 2023) | ||
7-90225200-G-A | not specified | Uncertain significance (Jan 17, 2023) | ||
7-90225239-G-A | not specified | Uncertain significance (Jun 05, 2023) | ||
7-90225240-G-T | not specified | Uncertain significance (Oct 03, 2022) | ||
7-90225243-A-G | not specified | Uncertain significance (Feb 14, 2023) | ||
7-90225301-G-T | STEAP2-related disorder | Likely benign (Aug 02, 2020) | ||
7-90225315-A-G | not specified | Uncertain significance (May 10, 2024) | ||
7-90225341-A-T | not specified | Uncertain significance (Apr 25, 2022) | ||
7-90225344-A-G | not specified | Uncertain significance (Jun 28, 2024) | ||
7-90225497-G-T | not specified | Uncertain significance (Aug 13, 2021) | ||
7-90225539-G-A | not specified | Uncertain significance (May 04, 2023) | ||
7-90225546-A-G | not specified | Uncertain significance (Nov 21, 2024) | ||
7-90225569-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
7-90225570-G-A | not specified | Uncertain significance (Nov 10, 2024) | ||
7-90226986-A-G | not specified | Uncertain significance (Feb 23, 2023) | ||
7-90227139-A-G | STEAP2-related disorder | Likely benign (Aug 17, 2022) | ||
7-90227189-T-G | not specified | Uncertain significance (Dec 19, 2022) | ||
7-90227216-C-G | not specified | Uncertain significance (Jun 22, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STEAP2 | protein_coding | protein_coding | ENST00000287908 | 4 | 70548 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.25e-7 | 0.900 | 125607 | 0 | 134 | 125741 | 0.000533 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.753 | 223 | 257 | 0.868 | 0.0000123 | 3187 |
Missense in Polyphen | 51 | 66.153 | 0.77094 | 839 | ||
Synonymous | 2.22 | 64 | 91.0 | 0.703 | 0.00000436 | 963 |
Loss of Function | 1.68 | 14 | 22.6 | 0.619 | 0.00000149 | 246 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000658 | 0.000656 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.000278 | 0.000277 |
European (Non-Finnish) | 0.000823 | 0.000818 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000394 | 0.000392 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Metalloreductase that has the ability to reduce both Fe(3+) to Fe(2+) and Cu(2+) to Cu(1+). Uses NAD(+) as acceptor (By similarity). {ECO:0000250}.;
- Pathway
- Mineral absorption - Homo sapiens (human);Copper homeostasis;Transferrin endocytosis and recycling;Transport of small molecules;Iron uptake and transport
(Consensus)
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.345
- rvis_EVS
- 0.51
- rvis_percentile_EVS
- 80.1
Haploinsufficiency Scores
- pHI
- 0.0344
- hipred
- N
- hipred_score
- 0.393
- ghis
- 0.445
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.140
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Steap2
- Phenotype
Gene ontology
- Biological process
- Golgi to plasma membrane transport;endocytosis;response to hormone;copper ion import;regulated exocytosis;iron ion homeostasis;oxidation-reduction process;iron ion import across cell outer membrane
- Cellular component
- endosome;early endosome;cytosol;plasma membrane;endosome membrane;trans-Golgi network transport vesicle;integral component of Golgi membrane
- Molecular function
- transporter activity;cupric reductase activity;metal ion binding;ferric-chelate reductase (NADPH) activity